Zdrowie i gospodarka · 24/10/2022
FDA Releases Draft Guidance for Characterizing Topical Drug Products in ANDAs
The FDA has published a draft guidance to help industry applicants properly characterize topical drug products in their abbreviated new drug applications (ANDAs), ensuring the quality and performance of these products.
Source: Federal Register — Food and Drug AdministrationOpen original release →